JAMP DOXYCYCLINE 20 MG
DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 20 MG · DIN 02528568 · JAMP PHARMA CORPORATION
Health Canada status: MARKETED
What is JAMP DOXYCYCLINE?
JAMP DOXYCYCLINE 20 MG contains DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02528568, held by JAMP PHARMA CORPORATION, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 03-May-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is JAMP DOXYCYCLINE used for?
JAMP Doxycycline is indicated for use as an adjunct to scaling and root planing to promote attachment level gain and to reduce pocket depth in patients with adult periodontitis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02528568 |
|---|---|
| Brand name | JAMP DOXYCYCLINE |
| Generic / active ingredient | DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 20 MG |
| Manufacturer | JAMP PHARMA CORPORATION |
| Strength | 20 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A01AB22 DOXYCYCLINE |
| AHFS class | 68:20.06 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 03-May-2024 |
| Original market date | 2024-04-22 00:00:00 |
How is it stored and handled?
All products are to be stored at controlled room temperatures of 15°C - 30°C and dispensed in tight, light-resistant containers (U.S.P.), protected from excessive humidity.
How is it supplied?
bottle of 60 capsules
What can be used instead?
Other Canadian products sharing ATC code A01AB22 DOXYCYCLINE. 2 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PMS-DOXYCYCLINE | 20 MG | CAPSULE | PHARMASCIENCE INC | MARKETED | DIN 02247104 |
| ATRIDOX | 8.8 % | GEL (CONTROLLED-RELEASE) | DEN-MAT HOLDINGS, LLC | DORMANT | DIN 02242473 |
| PMS-DOXYCYCLINE | 20 MG | CAPSULE | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02517817 |
Who else supplies DOXYCYCLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DOXYCYCLINE appears in 306 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.